Navigation Links
SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
Date:4/23/2009

d analysis platform that quantitatively and precisely measures genetic target material and variations. The company has exclusively licensed intellectual property rights for the development and commercialization of noninvasive prenatal genetic tests for use with the MassARRAY system and other platforms. SEQUENOM maintains a website at www.sequenom.com to which SEQUENOM regularly posts copies of its press releases as well as additional information about SEQUENOM. Interested persons can subscribe on the SEQUENOM website to email alerts or RSS feeds that are sent automatically when SEQUENOM issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

SEQUENOM(R) and MassARRAY(R) are trademarks of SEQUENOM, Inc.

    Company Contact
    Ian Clements
    Sr. Director, Corp. Communications
    +1 (858) 202-9000

    Investor Relations Contact
    Lippert/Heilshorn & Associates
    Jody Cain (jcain@lhai.com)
    Kevin Mc Cabe (kmccabe@lhai.com)
    +1 (310) 691-7100

    Media Relations
    Pure Communications
    Sheryl Seapy
    +1 (949) 608-0841


'/>"/>
SOURCE SEQUENOM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
2. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
3. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
4. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
5. Insmed to Host First Quarter 2009 Conference Call
6. Essilor : 2009 First Quarter Report
7. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
8. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
9. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
10. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
11. Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
(Date:8/3/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a ... autologous cell therapies, announced today that RepliCel,s CEO, David ... in Minneapolis, Minnesota on August 5 ... highlight RepliCel,s 18-month milestones including CE Mark for its RCI-02 ... clinical data from both RCT-01 (tendon) and RCS-01 (skin) clinical ...
(Date:7/31/2015)... KONG , July 31, 2015 China ... China,s leading provider of cord ... stem cell storage services, today announced that the Company ... the U.S. Securities and Exchange Commission. The filed Form ... ended March 31, 2015. The Form 20-F can be ...
(Date:7/30/2015)... , July 30, 2015   GenoSpace ... for the interpretation and analysis of genomic and ... Fischer has joined the company as Vice ... - http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace ... to integrate, interpret, analyze and explore complex sets ...
Breaking Biology Technology:Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2
... Dec. 17 Phosphagenics,Limited ("Phosphagenics") (ASX: POH, AIM: ... Phase 1 clinical trial that showed its,delivery technology, ... without causing disruption or irritation of any kind., ... the first company to,commercialize a sustained release oxycodone ...
... Provide Unprecedented Visibility into, Enterprise-Wide Spend Management Practices; Supplier Enablement Capability ... Spending with Preferred ... ... leader,in helping academic and research-centric organizations realize the,potential of strategic procurement, ...
... Dec. 17 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; ... clinical trial which is designed to support an ... for the treatment of patients,with NYHA Class II ... diligently on the ACCLAIM-II study,including the establishment of ...
Cached Biology Technology:Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 3AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services 2AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services 3Vasogen Provides an Update on ACCLAIM-II Preparations 2Vasogen Provides an Update on ACCLAIM-II Preparations 3Vasogen Provides an Update on ACCLAIM-II Preparations 4
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
(Date:7/30/2015)... 2015 Cellecta, Inc., a U.S.-based provider ... and biomarker discovery, announced the release of its ... all human protein coding genes. CRISPR technology enables ... gene,s function. Cellecta,s new Human Whole Genome CRISPR ... so that researchers can investigate in a single ...
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s ... in 2015 that relate to sales of FPC1025 for this smartphone ... MSEK for 2015. Jörgen Lantto, CEO of FPC, comments: ... China and we are proud that ... Axon , its first smartphone ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... a common chemotherapy agent, researchers at UCLA's Jonsson Cancer ... found a way to move an important biomarker expressed ... in a cell ?where it could not be accessed ... The discovery, outlined in the cover article of May ...
... ended a decade-long controversy over the process by which ... ?the fragrant substances plants produce and which are often ... and other animals were incapable of making these substances. ... control pheromone production," said Gary Blomquist, professor and chair ...
... University of North Carolina at Chapel Hill's newest "library" ... book lover, but it eventually will please thousands of ... it will undoubtedly contribute to improving crops that humans ... say. , Named Phytome, the unique library is a ...
Cached Biology News:UCLA cancer researchers shake loose hidden biomarker 2Researchers discover key gene involved in bark beetle pheromone production 2Unique library of plant genes germinates, takes root at UNC 2